Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Pharmexa slips after HCC data

Pharmexa (CSE:PHARMX) fell DKK2.40 (17%) to DKK11.50

Read the full 72 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE